Fiomi Diagnostics AB develops and manufacture:
Meritas® Troponin I, Meritas® BNP assays and Meritas® POC Analyzer

With its current and future menu of tests, sets a new standard for point-of-care testing, including the only guideline- compliant POC Troponin assay – the Meritas® Troponin I test. This allows fast, cost-effective and accurate triage, enabling rapid intervention for improved patient outcomes. 

Fiomi Diagnostics AB is a wholly owned subsidiary of Trinity Biotech plc. Trinity Biotech plc is a public company, specializing in the development, manufacture and marketing of clinical diagnostic products


Contact
Fiomi Diagnostics AB
Dag Hammarskjölds väg 52A
SE-751 83 Uppsala
Sweden
Tel: +46 18 56 08 90 
https://www.barncancerfonden.se/

Dag Hammarskjölds väg 52A